Editing Pfizer (section)

==== Controversy ====
In February 2021, after a year long investigation relying on unnamed officials, Pfizer was accused by [[The Bureau of Investigative Journalism]] (TBIJ) of employing "high-level bullying" against at least two [[Latin America]]n countries during negotiations to acquire COVID-19 vaccines, including requesting that the countries put sovereign assets as [[Collateral (finance)|collateral]] for payments.<ref name="bullied">{{Cite news |title=Investigation: Drugmaker 'bullied' Latin American nations |url=https://www.aljazeera.com/news/2021/3/11/investigation-pfizer-bullied-latin-american-nations |website=[[Al Jazeera English]] |date=March 11, 2021}}</ref> According to TBIJ, these negotiation tactics resulted in a months long delay in Pfizer reaching a vaccine agreement with one country and a complete failure to reach agreements with two other countries, including [[Argentina]] and Brazil.<ref name="bullied"/>

In November 2021, TBMJ published an article after obtaining information from a [[whistleblower]] from the Ventavia Research Group. Ventavia was hired by Pfizer as a research subcontractor. A regional director (whistleblower) who was employed at Ventavia Research Group has told ''The BMJ'' that the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in [[Pfizer–BioNTech COVID-19 vaccine#Clinical trials|Pfizer's pivotal phase III trial]]. The regional director, Brook Jackson, emailed a complaint to the US [[Food and Drug Administration]] (FDA). Ventavia fired her later the same day.<ref>{{cite news |last1=Thacker |first1=Paul |title=Covid-19: Researcher blows the whistle on data integrity issues in Pfizer's vaccine trial |url=https://www.bmj.com/content/375/bmj.n2635 |access-date=2 November 2021 |publisher=thebmj}}</ref> The [[European Medicines Agency]] (EMA) stated in a response to the [[European Parliament]], that "the deficiencies identified do not jeopardize the quality and integrity of the data from the main Comirnaty trial and have no impact on the benefit-risk assessment or on the conclusions on the safety, effectiveness and quality of the vaccine".<ref>{{Cite web |url=https://www.ema.europa.eu/en/documents/other/ema-reply-letter-members-european-parliament-ms-m-rivasi-mr-p-pedicini-ms-t-metz-concerning-covid-19_en.pdf |title=Reply letter on the Integrity of clinical data, additional clinical trials and studies, pharmacovigilance and mRNA COVID-19 vaccine safety |author=[[European Medicines Agency]] |date=3 December 2021 |access-date=2 February 2022}}</ref> ''[[Science-Based Medicine]]'' emphasized that Ventavia oversaw just three of the 153 clinical sites involved with Pfizer's trial and "a small fraction (~1,000 by the time the whistleblower was fired) of the trial's over ~44,000 subjects."<ref>{{Cite news |last=Gorski |first=David |author-link=David Gorski |date=November 8, 2021 |title=What the heck happened to The BMJ? |work=Science-Based Medicine |url=https://sciencebasedmedicine.org/what-the-heck-happened-to-the-bmj/ |access-date=May 16, 2023}}</ref>

On 10 October 2022, during a session of the [[European Parliament]]'s Special Committee on the COVID-19 Pandemic, Pfizer executive Janine Small testified that the company had not evaluated their [[Pfizer–BioNTech COVID-19 vaccine|COVID-19 vaccine]] for its ability to reduce transmission of the [[SARS-CoV-2]] virus prior to its release to the general public.<ref>{{Cite web |date=2022-10-10 |title=Special Committee on COVID-19 pandemic |url=https://multimedia.europarl.europa.eu/en/webstreaming/special-committee-on-covid-19-pandemic_20221010-1430-COMMITTEE-COVI |url-status=live |archive-url=https://web.archive.org/web/20221014010053/https://multimedia.europarl.europa.eu/en/webstreaming/special-committee-on-covid-19-pandemic_20221010-1430-COMMITTEE-COVI |archive-date=2022-10-14 |access-date=2022-10-14 |website=[[European Parliament]] Multimedia Centre }}</ref><ref>{{Cite web |last=TN World Desk |date=2022-10-13 |title=Pfizer admits it did not know whether its Covid vaccine prevented transmission of virus when rollout began |url=https://www.timesnownews.com/world/pfizer-admits-it-did-not-know-its-covid-vaccine-prevented-transmission-of-virus-when-rollout-began-article-94836651 |url-status=live |archive-url=https://archive.today/20221013205522/https://www.timesnownews.com/world/pfizer-admits-it-did-not-know-its-covid-vaccine-prevented-transmission-of-virus-when-rollout-began-article-94836651 |archive-date=2022-10-13 |access-date=2022-10-14 |website=[[TimesNow]] }}</ref> Dutch MEP [[Rob Roos]] described the admission as "scandalous".<ref>{{Cite web |last=Chung |first=Frank |date=2022-10-13 |title=Pfizer did not know whether Covid vaccine stopped transmission before rollout, executive admits |url=https://www.news.com.au/technology/science/human-body/pfizer-did-not-know-whether-covid-vaccine-stopped-transmission-before-rollout-executive-admits/news-story/f307f28f794e173ac017a62784fec414 |url-status=live |archive-url=https://web.archive.org/web/20221014110736/https://www.news.com.au/technology/science/human-body/pfizer-did-not-know-whether-covid-vaccine-stopped-transmission-before-rollout-executive-admits/news-story/f307f28f794e173ac017a62784fec414 |archive-date=2022-10-14 |access-date=2022-10-14 |website=[[News.com.au]]}}</ref> CEO [[Albert Bourla]] was slated to attend, but withdrew.<ref>{{Cite web |last=Bauer-Babef |first=Clara |date=2022-10-12 |title=Pfizer remains discreet about COVID vaccine purchase contracts |url=https://www.euractiv.com/section/coronavirus/news/pfizer-remains-discreet-about-covid-vaccine-purchase-contracts/ |url-status=live |archive-url=https://web.archive.org/web/20221013183554/https://www.euractiv.com/section/coronavirus/news/pfizer-remains-discreet-about-covid-vaccine-purchase-contracts/ |archive-date=2022-10-13 |access-date=2022-10-14 |website=[[Euractiv]] -GB}}</ref> Roos' statements in turn have been described as "misleading".<ref>{{Cite web |date=October 18, 2022 |first=Flora |last=Teoh |title=Scientific studies show that the Pfizer-BioNTech COVID-19 vaccine reduces transmission; claim by Rob Roos is misleading |url=https://science.feedback.org/review/scientific-studies-show-pfizer-biontech-covid-19-vaccine-reduces-transmission-claim-rob-roos-misleading/ |url-status=live |archive-url=https://web.archive.org/web/20240916075734/https://science.feedback.org/review/scientific-studies-show-pfizer-biontech-covid-19-vaccine-reduces-transmission-claim-rob-roos-misleading/ |archive-date=September 16, 2024 |access-date=September 16, 2024 |website=Science Feedback |publisher=Health Feedback -GB}}</ref>